New Treatment for Stroke Prevention in Patients with Atrial Fibrillation
Links shared publicly online about this topic.
- 908total visits
New Treatment for Stroke Prevention in Patients with Atrial Fibrillation
View full resource at hcplive.com
Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Stroke, Thrombotic Event
Most Recently Shared on August 31, 2010 at 1:47 pm By:
Researchers at ESC present data behind early halt of AVEROES trial due to 50% stroke risk reduction with apixaban http://hcp.lv/9P9AYv
New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients
networkedblogs.com — “New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients” View full resource at networkedblogs.com
Most Recently Shared on March 26, 2012 at 6:26 pm By:
Lisa Collier Cool Health Communicator
New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients http://t.co/YUjhJUQJ
New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients : Healthymagination
healthymagination.com — “Three new game-changing anticoagulants have been developed for the prevention of strokes in people with atrial fibrillation. The new designer drugs dabigatran, rivaroxaban and apixaban offer significant benefits compared to decades-old warfarin, but there are some downsides to consider.” View full resource at healthymagination.com
Most Recently Shared on March 26, 2012 at 4:45 pm By:
Herpes on Healthline Health Site
New designer drugs for people suffering with atrial fibrillation: http://t.co/n5MnEwEj
EMA updates dabigatran label due to increased fatal bleeds
cardiovascularbusiness.com — “The European Medicines Agency (EMA) has updated the safety label for Boehringer Ingelheim’s dabigatran (Pradaxa) after several cases of fatal bleeding events were reported. The number of increased bleeds may stem from the increased use of the drug as a result of approval of a new indication (preventing stroke and systemic embolism in non-valvular atrial fibrillation patients), EMA said in a statement.” View full resource at cardiovascularbusiness.com
Most Recently Shared on November 21, 2011 at 5:32 pm By:
CardioBusiness Health Magazine
EMA updates dabigatran label due to increased fatal bleeds - The European Medicines Agency (EMA) has updated the saf... http://t.co/LKyEslkQ
Alternative to Warfarin may be better for preventing stroke, with fewer side effects - News
virtualmedicalcentre.com — “A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation.” View full resource at virtualmedicalcentre.com
Most Recently Shared on September 9, 2011 at 2:10 pm By:
VirtualMedicalCentre Health Site
Alternative to Warfarin may be better for preventing stroke, with fewer side effects http://t.co/1lVsakq #Healthnews
Bayer, J&J Blood Thinner Gets FDA Panel Backing For New Indication
rttnews.com — “Blood thinner Xarelto, co-developed by Bayer HealthCare, a subsidiary of German chemical and pharmaceutical giant Bayer AG (BYR.L) (BAYRY.PK) and Johnson & Johnson (JNJ) won an FDA expert panel vote Thursday, backing the approval of the drug for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in the U.” View full resource at rttnews.com
Most Recently Shared on September 9, 2011 at 12:28 pm By:
Drugs and Devices OW OW Health
Bayer, J&J Stroke Drug Gets FDA Panel Backing - RTT News: USA TodayBayer, J&J Stroke Drug Gets FDA Panel B... http://t.co/ruIUBoN #drug
FDA Recommends Against Bayer and J&J Anti-Clot Drug
ibtimes.com — “The Food and Drug Administration has recommended against an immediate approval for Bayer AG and Johnson & Johnson’s anti-clotting drug, Xarelto, as a treatment to prevent strokes in patients with atrial fibrillation.” View full resource at ibtimes.com
Most Recently Shared on September 7, 2011 at 5:25 am By:
FDA Recommends Against Bayer and J&J Drug http://t.co/ZayOjki
Bayer, J&J Suffer FDA Setback - WSJ.com
online.wsj.com — “Food and Drug Administration staff recommended against an immediate approval for Johnson & Johnson and Bayer's anticlotting drug Xarelto as a treatment to prevent strokes in patients with atrial fibrillation.” View full resource at online.wsj.com
Most Recently Shared on September 6, 2011 at 5:24 pm By:
Bayer, J&J Suffer FDA Setback http://t.co/EbYPzWd
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA reviewer.” View full resource at qualitypointtech.net
Most Recently Shared on September 6, 2011 at 5:00 pm By:
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib: WASHINGTON (MedPage Today) -- Rivaroxaban (Xarelto) is ... http://t.co/6bEwbRZ
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:51 pm By:
HealthTrendster Health Executive
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib: WASHINGTON (MedPage Today… http://t.co/knMi5wv
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:11 pm By:
FDA reviewer slams Xarelto for stroke prevention in Afib: http://t.co/d4nW7Qp
Medical News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib - in Cardiovascular, Strokes from MedPage Today
medpagetoday.com — “WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA” View full resource at medpagetoday.com
Most Recently Shared on September 6, 2011 at 4:10 pm By:
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib http://t.co/NJ3BLJN
Stroke-risk patients to reap benefit of drug breakthrough - Wales News - News - WalesOnline
walesonline.co.uk — “THE first new drug of its kind in 50 years to prevent strokes in patients with atrial fibrillation has been licensed for use in the UK.” View full resource at walesonline.co.uk
Most Recently Shared on September 5, 2011 at 8:14 am By:
Drugs and Devices OW OW Health
Stroke-risk patients to reap benefit of drug breakthrough - WalesOnline: Zee NewsStroke-risk patients to r... http://t.co/eFlBIYG #drug
For Preventing Stroke, Reducing Bleeding And Saving Lives, Apixaban Superior To Warfarin
medicalnewstoday.com — “A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreo” View full resource at medicalnewstoday.com
Most Recently Shared on August 30, 2011 at 7:05 am By:
For Preventing Stroke, Reducing Bleeding And Saving Lives, Apixaban Superior To Warfarin http://mnt.to/3Zfy #stroke
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
labspaces.net — “A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in substantially less bleeding and also results in lower mortality.” View full resource at labspaces.net
Most Recently Shared on August 29, 2011 at 3:15 pm By:
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives - http://t.co/4cAHexl
Stroke Prevention Therapy Use Low Among High-Risk Patients With Atrial Fibrillation (AF) - Drugs.com MedNews
drugs.com — “GARFIELD Registry Data presented at ESC CONGRESS 2011 New data show that, worldwide, one in three patients with atrial fibrillation (AF) who are at high risk fo” View full resource at drugs.com
Most Recently Shared on August 29, 2011 at 11:16 am By:
Drugs and Devices OW OW Health
Stroke Prevention Therapy Use Low Among High-Risk Patients With Atrial Fibrillation (AF): ---- GARFIELD Re... http://t.co/DxRA9jq #drug
Advertisement
